Paola Conti
Via Mangiagalli 25
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models.
Journal: Journal of medicinal chemistry
Published: May 26, 2026
Targeting ALDH7A1 with covalent inhibitors reveals new chemical space for prostate cancer therapy.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: May 11, 2026
From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach.
Journal: European journal of medicinal chemistry
Published: July 01, 2025
Two-Step Flow Amidation of Natural Phenolic Acids as Antiradical and Antimicrobial Agents.
Journal: Journal of natural products
Published: March 31, 2025
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents.
Journal: ACS infectious diseases
Published: May 08, 2024
Discovery and characterization of a new class of NAD+-independent SIRT1 activators.
Journal: Pharmacological research
Published: February 28, 2024
Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis.
Journal: Biology direct
Published: November 07, 2023
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: March 07, 2023
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells.
Journal: European journal of medicinal chemistry
Published: January 17, 2023
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds.
Journal: ACS medicinal chemistry letters
Published: June 25, 2021
Last Updated: 09/26/2026